(Q40073564)

English

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo.

scientific article

Statements

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. (English)
Robert D Loberg
Chi Ying
Matt Craig
Lashon L Day
Erin Sargent
Chris Neeley
Kirk Wojno
Linda A Snyder
1 October 2007
9417-9424

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit